Biotechnology Companies' Annual Reports & Investor Relations Material

582 Companies

IPHA

Innate Pharma S.A.

French biotechnology company Innate Pharma S.A. is making strides in the field of immunotherapy for cancer treatment. Its portfolio includes several products, such as Lacutamab (IPH4102), a KIR3DL2...

Innate Pharma S.A. Annual Report 2023

Healthcare Biotechnology NASDAQ 201-500

TCON

TRACON Pharmaceuticals

San Diego-based TRACON Pharmaceuticals, a biopharmaceutical company, is dedicated to developing and commercializing cutting-edge cancer therapeutics in the United States. Its clinical stage product...

TRACON Pharmaceuticals Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

CDTX

Cidara Therapeutics Inc

San Diego-based biotechnology company Cidara Therapeutics Inc. focuses on the development and commercialisation of long-acting anti-infectives for the treatment and prevention of infectious disease...

Cidara Therapeutics Inc Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

JAZZ

Jazz Pharmaceuticals

Jazz Pharmaceuticals plc, a biopharmaceutical company based in Dublin, Ireland, is making waves in the field of pharmaceutical products for unmet medical needs. With a focus on neuroscience and onc...

Jazz Pharmaceuticals Annual Report 2023

Healthcare Biotechnology NASDAQ 501-1000

TNXP

Tonix Pharmaceuticals Holding Corp.

Clinical-stage biopharmaceutical company Tonix Pharmaceuticals Holding Corp. is dedicated to developing cutting-edge therapeutics and vaccines that can treat and prevent a wide range of human disea...

Tonix Pharmaceuticals Holding Corp. Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

MDNA

Medicenna Therapeutics

Medicenna, a clinical stage immunotherapy company, is focusing on developing new versions of IL-2, IL-4, and IL-13 Superkines, and Empowered Cytokines™ (ECs) for cancer treatment. The company's lea...

Medicenna Therapeutics Annual Report 2023

Healthcare Biotechnology TSX 1-10

CERS

Cerus

Cerus Corporation, a biomedical products company, is committed to developing and commercializing its proprietary technology, the INTERCEPT Blood System, to enhance blood safety. The company's innov...

Cerus Annual Report 2023

Healthcare Biotechnology NASDAQ 201-500

ABCA

Abcam Plc

Abcam plc is a UK-based company that specializes in the development, marketing and distribution of antibodies and other related products. The company sells its products globally through its online ...

Abcam Plc Annual Report 2021

Healthcare Biotechnology LSE 1001-5000

XCUR

Exicure, Inc.

Chicago-based Exicure Inc., an early-phase biotech firm, is working on developing nucleic acid therapies using ribonucleic acid to target validated goals. Their preclinical drug candidate features ...

Exicure, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

BLCM

Bellicum Pharmaceuticals Inc

Bellicum Pharmaceuticals, Inc. is making strides in the biopharmaceutical industry as it focuses on the development of innovative cellular immunotherapies for hematological cancers and solid tumors...

Bellicum Pharmaceuticals Inc Annual Report 2021

Healthcare Biotechnology NASDAQ 51-200

CNST

Constellation Pharmaceuticals, Inc.

Constellation Pharmaceuticals is a biopharmaceutical company working to address unmet medical needs in cancer patients by selectively modulating gene expression. The company's focus is on epigeneti...

Constellation Pharmaceuticals, Inc. Annual Report 2019

Healthcare Biotechnology NASDAQ 51-200

ORPH

Open Orphan plc

Open Orphan Limited is a niche CRO pharmaceutical services group that specializes in testing vaccines and antivirals through human challenge clinical trials. It is a world leader in this area and o...

Open Orphan plc Annual Report 2020

Healthcare Biotechnology LSE 51-200

RENE

ReNeuron

ReNeuron Group plc is a UK-based company that specializes in cell-based therapies. Their flagship product is the CTX stem cell therapy candidate, which is currently in the partnering stage in China...

ReNeuron Annual Report 2023

Healthcare Biotechnology LSE 11-50

TCRR

TCR2 Therapeutics Inc.

TCR2 Therapeutics Inc., a clinical-stage cell therapy company, is tackling cancer head-on with its groundbreaking T cell receptor (TCR) therapies. The company's lead product, gavo-cel, is a mono TC...

TCR2 Therapeutics Inc. Annual Report 2021

Healthcare Biotechnology NASDAQ 51-200

ARDX

Ardelyx Inc

Ardelyx Inc., a biopharmaceutical firm, has been making strides in discovering, developing, and selling medicines to address therapeutic areas in gastrointestinal and cardiorenal care both domestic...

Ardelyx Inc Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200